Abbott Labs is looking to raise about $20 billion from a bond sale to help fund its acquisition of Exact Sciences, marking one of the biggest offerings this year.
Everything we know about the show's potential return so far.
Zacks Investment Research on MSN
Abbott (ABT) ascends while market falls: Some facts to note
Abbott (ABT) ended the recent trading session at $115.29, demonstrating a +2.74% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of ...
24/7 Wall St. on MSN
Abbott Labs just extended its dividend aristocrat status: What comes next?
Quick Read Abbott Laboratories (ABT) raised its quarterly dividend to $0.63 with a 60.4% free cash flow payout ratio.
Abbott Laboratories (NYSE:ABT) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results